Crosswalk: • FFS Annual Report

2020 (old version)	2021 (new version)	Type of Change	Reason for Change	Burden Change
N/A	Updated grammer and formatting of questions for easier understanding, with some streamlining of responses	Rev	To make it easier for repondent to complete the surveys.	Updated setence structure and formatting for easier understanding and to decrease work burden for respondants by 5 minutes
N/A	Spelled out acroynms for easier understanding	Rev	To make it easier for repondent to complete the surveys.	To increase understanding for respondants-decrease work burden by 5 minutes
N/A	Added questions about psychotrophic medications in children to address a GAO recommendation ANTIDEPRESSANTS 5. Does your state have a documented program in place to either manage or monitor the appropriate use of antidepressants drugs in children? a. Does your state either manage or monitor only children in foster care or all children b. Does your state have edits in place to monitor? c. Please briefly explain the specifics of your documented antidepressant monitoring program(s). If No,” does your state plan on implementing an antidepressant monitoring program in the future? MOOD STABILIZERS 6. Does your state have a documented program in place to either manage or monitor the appropriate use of mood stabilizing drugs in children? a. Does your state either manage or monitor only children in foster care or all children b. Does your state have edits in place to monitor? c. Please briefly explain the specifics of your documented mood stabilizer monitoring program(s). If “No,” does your state plan on implementing a mood stabilizer monitoring program in the future? ANTIANXIETY/SEDATIVES 7. Does your state have a documented program in place to either manage or monitor the appropriate use of antianxiety/sedative drugs in children? a. Does your state either manage or monitor only children in foster care or all children b. Does your state have edits in place to monitor? c. Please briefly explain the specifics of your documented antianxiety/sedative monitoring program(s). If “No,” does your state plan on implementing a antianxiety/sedative monitoring program in the future?	Add	GAO compliance	Increased work burden to collect information by 30 minutes
When the pharmacist receives an early refill DUR alert message that requires the pharmacist’s review, does your state’s policy allow the pharmacist to override for situations such as	Streamlined responses and removed subquestions to decrease total number of questions for the states.	Rev	To make it easier for repondent to complete the surveys.	Decrease work burden for respondants by 10 minutes
Individual questions about automated retrospective reviews	Subquestions were removed/streamlined into a single question regarding comprehensive retrospective reviews	Removed	To make it easier for repondent to complete the surveys.	Decrease work burden for respondants by 10 minutes
			total:	No net change